(AVD) American Vanguard - Ratings and Ratios

American Vanguard Corporation is a global supplier of specialized chemicals for the agricultural, commercial, and consumer sectors. The company has a diverse portfolio of products, including insecticides, fungicides, herbicides, and other crop protection chemicals, as well as products for turf and ornamental plants, and human and animal health protection. With a presence in the US and international markets, American Vanguard Corporation leverages its extensive distribution network, including national distribution companies, buying groups, co-operatives, and wholly-owned distributors, to deliver its products to customers.

The companys product offerings cater to various industries, including agriculture, landscaping, and pest control. American Vanguard Corporations chemicals are designed to enhance crop yields, protect plants from pests and diseases, and promote overall plant health. The companys commitment to innovation and quality has enabled it to establish a strong reputation in the market, with a customer base that includes major agricultural producers, landscaping companies, and pest control operators.

Analyzing the , we observe that the stocks current price is $4.18, slightly below its 20-day simple moving average (SMA) of $4.19. The 50-day SMA is $4.28, while the 200-day SMA is $5.32, indicating a longer-term downtrend. The average true range (ATR) is 0.24, representing a 5.63% daily price fluctuation. The stocks 52-week high and low are $9.62 and $3.47, respectively, indicating significant price volatility. Based on this technical analysis, we can anticipate potential support around $4.00 and resistance near $4.50.

Examining the , we note that American Vanguard Corporation has a market capitalization of $128.11 million and a forward price-to-earnings (P/E) ratio of 15.08. The companys return on equity (RoE) is -8.13%, indicating a negative return on shareholders equity. Considering the current price, technical trends, and fundamental data, we forecast that the stock may experience a short-term bounce towards $4.50, driven by potential buying interest near the $4.00 support level. However, the long-term downtrend and negative RoE may continue to weigh on the stocks performance, potentially limiting its upside potential. A more detailed analysis of the companys financials and industry trends is necessary to confirm this forecast.